[{"id":"dba0e6e2-594f-4f87-9d25-36bb519247e2","acronym":"","url":"https://clinicaltrials.gov/study/NCT01240590","created_at":"2021-01-18T04:59:45.037Z","updated_at":"2024-07-02T16:37:23.615Z","phase":"Phase 1/2","brief_title":"A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC)","source_id_and_acronym":"NCT01240590","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" BRAF","pipe":"","alterations":" ","tags":["BRAF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • crolibulin (EPC2407)"],"overall_status":"Completed","enrollment":" Enrollment 27","initiation":"Initiation: 01/26/2011","start_date":" 01/26/2011","primary_txt":" Primary completion: 08/31/2015","primary_completion_date":" 08/31/2015","study_txt":" Completion: 12/31/2016","study_completion_date":" 12/31/2016","last_update_posted":"2017-04-10"}]